VP]{W%}YFMCEKB$A#W)M&P$[T?Z5Y!VN*)U2FSC:IX|B[7K
SYSTEM PROCESSING...
VP]{W%}YFMCEKB$A#W)M&P$[T?Z5Y!VN*)U2FSC:IX|B[7K
SYSTEM PROCESSING...
Posted: 2025-07-16 18:08:34 UTC

This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-07-16 18:09:05 UTC
Verified By
Rollup News
Biocon is planning to launch a generic version of the obesity drug Wegovy in India and Canada within the next two years, according to the CEO.
Biocon's plan to launch a generic Wegovy
Target markets: India and Canada
Timeline: Next 2 years
Developing and manufacturing a generic version of Wegovy
Navigating regulatory approvals in India and Canada
Competing with existing obesity drugs in the market